Brean Murray Carret & Co. Starts Pharmasset (VRUS) at Buy, Price Target Offers 79% Upside
Tweet Send to a Friend
Brean Murray Carret & Co. initiates coverage on shares of Pharmasset (NASDAQ: VRUS) with a Buy rating and $174 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
